|
|
|||||||||||
The British Journal of Psychiatry 148: 52-57 (1986)
© 1986 The Royal College of Psychiatrists
JH Kocsis, I Hanin, C Bowden and D Brunswick
Plasma drug concentrations and clinical response were measured in two groups of hospitalised depressed patients, who received amitriptyline or imipramine double-blind, in a dosage of 250 mg for four weeks. Virtually no significant linear or curvilinear relationships were found between any plasma measure and any measure of clinical response. Modest but significant direct relationships were found between age and concentration of parent drugs but not demethylated metabolites. Blood drug level measurement therefore appears to be of little value in monitoring drug treatment of depressed in-patients.
This article has been cited by other articles:
![]() |
A. V. Zima, J. Qin, M. Fill, and L. A. Blatter Tricyclic antidepressant amitriptyline alters sarcoplasmic reticulum calcium handling in ventricular myocytes Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2008 - H2016. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. BARBUI and M. HOTOPF Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials The British Journal of Psychiatry, February 1, 2001; 178(2): 129 - 144. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |